Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pei Tu Ning Feng Tang for Tourette Syndrome
NCT07417371Completed
- Start
- Apr 2026
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Pei Tu Ning Feng Tang in Tourette syndrome (TS). Primary endpoints: Functional near-infrared spectroscopy brain function activation at 1 month, Relative and absolute quantitative analysis of the gut microbiota at 1 month and 5 more. Started Apr 2026; status: completed.
02
Drugs
Pei Tu Ning Feng Tang
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on NCT07417371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07417371.